← Back to search

Amber

RNA writing (trans-splicing) for correction of genetic diseases

a16zActive

What they do

Problem

Genetic diseases caused by faulty genes require effective ways to correct or bypass harmful mutations.

Solution

The company uses RNA writing via trans-splicing to repair or replace defective RNA transcripts to correct genetic disease at the RNA level.

Who it's for

Biopharma companies and clinical researchers developing RNA-based therapies for patients with genetic diseases.

Company timeline

Similar startups